Specifications
Item Number | 321907 |
---|
Administration Form | Oral |
---|
For Use With | Dogs & Cats |
---|
Generic Name | Milbehart |
---|
Common Brand Name(s) | Interceptor |
---|
Lifestage | Puppy, Kitten |
---|
Breed Size | Extra Small Breeds, Small Breeds |
---|
Product Form | Chewable Tablet |
---|
Strength | 5.75 mg milbemycin oxime |
---|
Health Condition | Heartworms |
---|
Drug Type | Parasiticide |
---|
Uses
MILBEHART Flavored Tablets are indicated for use in the prevention of heartworm disease caused by Dirofilaria immitis, the control of adult Ancylostoma caninum (hookworm), and the removal and control of adult Toxocara canis and Toxascaris leonina (roundworms) and Trichuris vulpis (whipworm) infections in dogs and in puppies four weeks of age or greater and two pounds body weight or greater. MILBEHART Flavored Tablets for Cats are indicated for use in the prevention of heartworm disease caused by Dirofilaria immitis, and the removal of adult Ancylostoma tubaeforme (hookworm) and Toxocara cati (roundworm) in cats and kittens six weeks of age or greater and 1.5 lbs. body weight or greater.
Possible Side Effects
The following adverse reactions have been reported following the use of MILBEHART Flavored Tablets: Depression/lethargy, vomiting, ataxia, anorexia, diarrhea, convulsions, weakness and hypersalivation.
Drug & Food Interactions
Do not use in puppies less than four weeks of age or less than two pounds of body weight. Prior to initiation of the MILBEHART Flavored Tablets treatment program, dogs should be tested for existing heartworm infections. Infected dogs should be treated to remove adult heartworms and microfilariae prior to initiating treatment with MILBEHART Flavored Tablets. Mild, transient hypersensitivity reactions manifested as labored respiration, vomiting, salivation and lethargy, have been noted in some treated dogs carrying a high number of circulating microfilariae. These reactions are presumably caused by release of protein from dead or dying microfilariae.
Precautions
Do not use in puppies less than four weeks of age or less than two pounds of body weight. Prior to initiation of the MILBEHART Flavored Tablets treatment program, dogs should be tested for existing heartworm infections. Infected dogs should be treated to remove adult heartworms and microfilariae prior to initiating treatment with MILBEHART Flavored Tablets. Mild, transient hypersensitivity reactions manifested as labored respiration, vomiting, salivation and lethargy, have been noted in some treated dogs carrying a high number of circulating microfilariae. These reactions are presumably caused by release of protein from dead or dying microfilariae.
Comment